nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—Lenalidomide—hematologic cancer	0.141	0.209	CbGbCtD
Trisalicylate-choline—PTGS2—Thalidomide—hematologic cancer	0.075	0.111	CbGbCtD
Trisalicylate-choline—PTGS1—Bortezomib—hematologic cancer	0.0727	0.108	CbGbCtD
Trisalicylate-choline—PTGS1—Thalidomide—hematologic cancer	0.0634	0.0941	CbGbCtD
Trisalicylate-choline—PTGS1—Ifosfamide—hematologic cancer	0.0558	0.0828	CbGbCtD
Trisalicylate-choline—PTGS1—Imatinib—hematologic cancer	0.0533	0.0791	CbGbCtD
Trisalicylate-choline—PTGS2—Triamcinolone—hematologic cancer	0.052	0.0772	CbGbCtD
Trisalicylate-choline—PTGS2—Betamethasone—hematologic cancer	0.0446	0.0662	CbGbCtD
Trisalicylate-choline—PTGS2—Cisplatin—hematologic cancer	0.0321	0.0477	CbGbCtD
Trisalicylate-choline—PTGS2—Etoposide—hematologic cancer	0.0316	0.0469	CbGbCtD
Trisalicylate-choline—PTGS1—Etoposide—hematologic cancer	0.0267	0.0396	CbGbCtD
Trisalicylate-choline—PTGS2—Dexamethasone—hematologic cancer	0.026	0.0385	CbGbCtD
Trisalicylate-choline—PTGS2—ovarian follicle—hematologic cancer	0.00743	0.556	CbGeAlD
Trisalicylate-choline—PTGS1—hematopoietic system—hematologic cancer	0.000938	0.0702	CbGeAlD
Trisalicylate-choline—PTGS2—hematopoietic system—hematologic cancer	0.000896	0.0671	CbGeAlD
Trisalicylate-choline—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000718	0.209	CbGdCrCtD
Trisalicylate-choline—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000718	0.209	CbGdCrCtD
Trisalicylate-choline—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000702	0.205	CbGdCrCtD
Trisalicylate-choline—PTGS1—blood—hematologic cancer	0.000621	0.0465	CbGeAlD
Trisalicylate-choline—PTGS2—blood—hematologic cancer	0.000594	0.0445	CbGeAlD
Trisalicylate-choline—PTGS2—bone marrow—hematologic cancer	0.000575	0.043	CbGeAlD
Trisalicylate-choline—PTGS1—lung—hematologic cancer	0.000545	0.0408	CbGeAlD
Trisalicylate-choline—PTGS2—lung—hematologic cancer	0.000521	0.039	CbGeAlD
Trisalicylate-choline—PTGS1—testis—hematologic cancer	0.000514	0.0385	CbGeAlD
Trisalicylate-choline—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000433	0.126	CbGdCrCtD
Trisalicylate-choline—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000433	0.126	CbGdCrCtD
Trisalicylate-choline—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000423	0.124	CbGdCrCtD
Trisalicylate-choline—PTGS1—lymph node—hematologic cancer	0.000373	0.0279	CbGeAlD
Trisalicylate-choline—PTGS2—lymph node—hematologic cancer	0.000356	0.0267	CbGeAlD
Trisalicylate-choline—Rash—Vinorelbine—hematologic cancer	9.16e-05	0.000383	CcSEcCtD
Trisalicylate-choline—Dermatitis—Vinorelbine—hematologic cancer	9.15e-05	0.000383	CcSEcCtD
Trisalicylate-choline—Headache—Vinorelbine—hematologic cancer	9.1e-05	0.000381	CcSEcCtD
Trisalicylate-choline—Asthma—Doxorubicin—hematologic cancer	9.09e-05	0.00038	CcSEcCtD
Trisalicylate-choline—Oedema—Triamcinolone—hematologic cancer	9.04e-05	0.000378	CcSEcCtD
Trisalicylate-choline—Pruritus—Alitretinoin—hematologic cancer	9.03e-05	0.000378	CcSEcCtD
Trisalicylate-choline—Sweating—Methotrexate—hematologic cancer	8.97e-05	0.000375	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Cisplatin—hematologic cancer	8.96e-05	0.000375	CcSEcCtD
Trisalicylate-choline—Weight increased—Epirubicin—hematologic cancer	8.94e-05	0.000374	CcSEcCtD
Trisalicylate-choline—Pruritus—Ifosfamide—hematologic cancer	8.93e-05	0.000373	CcSEcCtD
Trisalicylate-choline—Shock—Triamcinolone—hematologic cancer	8.89e-05	0.000372	CcSEcCtD
Trisalicylate-choline—Dizziness—Thalidomide—hematologic cancer	8.87e-05	0.000371	CcSEcCtD
Trisalicylate-choline—Somnolence—Etoposide—hematologic cancer	8.86e-05	0.000371	CcSEcCtD
Trisalicylate-choline—Nausea—Bortezomib—hematologic cancer	8.84e-05	0.00037	CcSEcCtD
Trisalicylate-choline—Epistaxis—Methotrexate—hematologic cancer	8.83e-05	0.000369	CcSEcCtD
Trisalicylate-choline—Vomiting—Thiotepa—hematologic cancer	8.82e-05	0.000369	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Carmustine—hematologic cancer	8.82e-05	0.000369	CcSEcCtD
Trisalicylate-choline—Nausea—Bleomycin—hematologic cancer	8.77e-05	0.000367	CcSEcCtD
Trisalicylate-choline—Drowsiness—Epirubicin—hematologic cancer	8.76e-05	0.000366	CcSEcCtD
Trisalicylate-choline—Erythema—Prednisone—hematologic cancer	8.75e-05	0.000366	CcSEcCtD
Trisalicylate-choline—Rash—Thiotepa—hematologic cancer	8.75e-05	0.000366	CcSEcCtD
Trisalicylate-choline—Dermatitis—Thiotepa—hematologic cancer	8.74e-05	0.000366	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Triamcinolone—hematologic cancer	8.74e-05	0.000365	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Alitretinoin—hematologic cancer	8.73e-05	0.000365	CcSEcCtD
Trisalicylate-choline—Headache—Thiotepa—hematologic cancer	8.69e-05	0.000364	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Etoposide—hematologic cancer	8.66e-05	0.000362	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Ifosfamide—hematologic cancer	8.63e-05	0.000361	CcSEcCtD
Trisalicylate-choline—Nausea—Vinorelbine—hematologic cancer	8.63e-05	0.000361	CcSEcCtD
Trisalicylate-choline—Vomiting—Thalidomide—hematologic cancer	8.53e-05	0.000357	CcSEcCtD
Trisalicylate-choline—Dizziness—Carmustine—hematologic cancer	8.52e-05	0.000356	CcSEcCtD
Trisalicylate-choline—Pain—Etoposide—hematologic cancer	8.52e-05	0.000356	CcSEcCtD
Trisalicylate-choline—Constipation—Etoposide—hematologic cancer	8.52e-05	0.000356	CcSEcCtD
Trisalicylate-choline—Rash—Thalidomide—hematologic cancer	8.46e-05	0.000354	CcSEcCtD
Trisalicylate-choline—Dermatitis—Thalidomide—hematologic cancer	8.45e-05	0.000354	CcSEcCtD
Trisalicylate-choline—Dizziness—Alitretinoin—hematologic cancer	8.44e-05	0.000353	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Vincristine—hematologic cancer	8.42e-05	0.000352	CcSEcCtD
Trisalicylate-choline—Headache—Thalidomide—hematologic cancer	8.41e-05	0.000352	CcSEcCtD
Trisalicylate-choline—Pain—Prednisolone—hematologic cancer	8.41e-05	0.000352	CcSEcCtD
Trisalicylate-choline—Hepatitis—Methotrexate—hematologic cancer	8.4e-05	0.000351	CcSEcCtD
Trisalicylate-choline—Sweating—Epirubicin—hematologic cancer	8.4e-05	0.000351	CcSEcCtD
Trisalicylate-choline—Dizziness—Ifosfamide—hematologic cancer	8.34e-05	0.000349	CcSEcCtD
Trisalicylate-choline—Weight increased—Doxorubicin—hematologic cancer	8.27e-05	0.000346	CcSEcCtD
Trisalicylate-choline—Epistaxis—Epirubicin—hematologic cancer	8.26e-05	0.000346	CcSEcCtD
Trisalicylate-choline—Pruritus—Gemcitabine—hematologic cancer	8.26e-05	0.000345	CcSEcCtD
Trisalicylate-choline—Nausea—Thiotepa—hematologic cancer	8.24e-05	0.000345	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Etoposide—hematologic cancer	8.21e-05	0.000343	CcSEcCtD
Trisalicylate-choline—Oedema—Dexamethasone—hematologic cancer	8.2e-05	0.000343	CcSEcCtD
Trisalicylate-choline—Oedema—Betamethasone—hematologic cancer	8.2e-05	0.000343	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Irinotecan—hematologic cancer	8.2e-05	0.000343	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Mitoxantrone—hematologic cancer	8.2e-05	0.000343	CcSEcCtD
Trisalicylate-choline—Vomiting—Carmustine—hematologic cancer	8.19e-05	0.000343	CcSEcCtD
Trisalicylate-choline—Dizziness—Vincristine—hematologic cancer	8.13e-05	0.00034	CcSEcCtD
Trisalicylate-choline—Rash—Carmustine—hematologic cancer	8.13e-05	0.00034	CcSEcCtD
Trisalicylate-choline—Dermatitis—Carmustine—hematologic cancer	8.12e-05	0.00034	CcSEcCtD
Trisalicylate-choline—Vomiting—Alitretinoin—hematologic cancer	8.12e-05	0.00034	CcSEcCtD
Trisalicylate-choline—Drowsiness—Doxorubicin—hematologic cancer	8.1e-05	0.000339	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Prednisolone—hematologic cancer	8.1e-05	0.000339	CcSEcCtD
Trisalicylate-choline—Headache—Carmustine—hematologic cancer	8.07e-05	0.000338	CcSEcCtD
Trisalicylate-choline—Shock—Betamethasone—hematologic cancer	8.07e-05	0.000337	CcSEcCtD
Trisalicylate-choline—Shock—Dexamethasone—hematologic cancer	8.07e-05	0.000337	CcSEcCtD
Trisalicylate-choline—Rash—Alitretinoin—hematologic cancer	8.05e-05	0.000337	CcSEcCtD
Trisalicylate-choline—Dermatitis—Alitretinoin—hematologic cancer	8.04e-05	0.000336	CcSEcCtD
Trisalicylate-choline—Vomiting—Ifosfamide—hematologic cancer	8.02e-05	0.000336	CcSEcCtD
Trisalicylate-choline—Headache—Alitretinoin—hematologic cancer	8e-05	0.000335	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Gemcitabine—hematologic cancer	7.98e-05	0.000334	CcSEcCtD
Trisalicylate-choline—Nausea—Thalidomide—hematologic cancer	7.97e-05	0.000333	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Triamcinolone—hematologic cancer	7.96e-05	0.000333	CcSEcCtD
Trisalicylate-choline—Rash—Ifosfamide—hematologic cancer	7.96e-05	0.000333	CcSEcCtD
Trisalicylate-choline—Dermatitis—Ifosfamide—hematologic cancer	7.95e-05	0.000332	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Methotrexate—hematologic cancer	7.94e-05	0.000332	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Dexamethasone—hematologic cancer	7.93e-05	0.000332	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Betamethasone—hematologic cancer	7.93e-05	0.000332	CcSEcCtD
Trisalicylate-choline—Dizziness—Irinotecan—hematologic cancer	7.92e-05	0.000331	CcSEcCtD
Trisalicylate-choline—Urticaria—Etoposide—hematologic cancer	7.92e-05	0.000331	CcSEcCtD
Trisalicylate-choline—Hepatitis—Epirubicin—hematologic cancer	7.86e-05	0.000329	CcSEcCtD
Trisalicylate-choline—Tinnitus—Methotrexate—hematologic cancer	7.83e-05	0.000328	CcSEcCtD
Trisalicylate-choline—Vomiting—Vincristine—hematologic cancer	7.82e-05	0.000327	CcSEcCtD
Trisalicylate-choline—Anorexia—Dexamethasone—hematologic cancer	7.82e-05	0.000327	CcSEcCtD
Trisalicylate-choline—Anorexia—Betamethasone—hematologic cancer	7.82e-05	0.000327	CcSEcCtD
Trisalicylate-choline—Urticaria—Prednisolone—hematologic cancer	7.81e-05	0.000327	CcSEcCtD
Trisalicylate-choline—Sweating—Doxorubicin—hematologic cancer	7.77e-05	0.000325	CcSEcCtD
Trisalicylate-choline—Rash—Vincristine—hematologic cancer	7.76e-05	0.000324	CcSEcCtD
Trisalicylate-choline—Dermatitis—Vincristine—hematologic cancer	7.75e-05	0.000324	CcSEcCtD
Trisalicylate-choline—Pain—Triamcinolone—hematologic cancer	7.73e-05	0.000323	CcSEcCtD
Trisalicylate-choline—Headache—Vincristine—hematologic cancer	7.71e-05	0.000322	CcSEcCtD
Trisalicylate-choline—Hypotension—Betamethasone—hematologic cancer	7.66e-05	0.000321	CcSEcCtD
Trisalicylate-choline—Hypotension—Dexamethasone—hematologic cancer	7.66e-05	0.000321	CcSEcCtD
Trisalicylate-choline—Nausea—Carmustine—hematologic cancer	7.65e-05	0.00032	CcSEcCtD
Trisalicylate-choline—Epistaxis—Doxorubicin—hematologic cancer	7.64e-05	0.00032	CcSEcCtD
Trisalicylate-choline—Vomiting—Irinotecan—hematologic cancer	7.62e-05	0.000319	CcSEcCtD
Trisalicylate-choline—Vomiting—Mitoxantrone—hematologic cancer	7.62e-05	0.000319	CcSEcCtD
Trisalicylate-choline—Nausea—Alitretinoin—hematologic cancer	7.58e-05	0.000317	CcSEcCtD
Trisalicylate-choline—Rash—Mitoxantrone—hematologic cancer	7.55e-05	0.000316	CcSEcCtD
Trisalicylate-choline—Rash—Irinotecan—hematologic cancer	7.55e-05	0.000316	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mitoxantrone—hematologic cancer	7.55e-05	0.000316	CcSEcCtD
Trisalicylate-choline—Dermatitis—Irinotecan—hematologic cancer	7.55e-05	0.000316	CcSEcCtD
Trisalicylate-choline—Headache—Mitoxantrone—hematologic cancer	7.51e-05	0.000314	CcSEcCtD
Trisalicylate-choline—Headache—Irinotecan—hematologic cancer	7.51e-05	0.000314	CcSEcCtD
Trisalicylate-choline—Nausea—Ifosfamide—hematologic cancer	7.49e-05	0.000313	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Triamcinolone—hematologic cancer	7.45e-05	0.000312	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Cisplatin—hematologic cancer	7.44e-05	0.000311	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Epirubicin—hematologic cancer	7.43e-05	0.000311	CcSEcCtD
Trisalicylate-choline—Vomiting—Gemcitabine—hematologic cancer	7.42e-05	0.00031	CcSEcCtD
Trisalicylate-choline—Rash—Gemcitabine—hematologic cancer	7.36e-05	0.000308	CcSEcCtD
Trisalicylate-choline—Dermatitis—Gemcitabine—hematologic cancer	7.35e-05	0.000307	CcSEcCtD
Trisalicylate-choline—Tinnitus—Epirubicin—hematologic cancer	7.33e-05	0.000307	CcSEcCtD
Trisalicylate-choline—Erythema—Methotrexate—hematologic cancer	7.31e-05	0.000306	CcSEcCtD
Trisalicylate-choline—Headache—Gemcitabine—hematologic cancer	7.31e-05	0.000306	CcSEcCtD
Trisalicylate-choline—Nausea—Vincristine—hematologic cancer	7.31e-05	0.000306	CcSEcCtD
Trisalicylate-choline—Flushing—Epirubicin—hematologic cancer	7.3e-05	0.000305	CcSEcCtD
Trisalicylate-choline—Hepatitis—Doxorubicin—hematologic cancer	7.28e-05	0.000304	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Dexamethasone—hematologic cancer	7.22e-05	0.000302	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Betamethasone—hematologic cancer	7.22e-05	0.000302	CcSEcCtD
Trisalicylate-choline—Urticaria—Triamcinolone—hematologic cancer	7.18e-05	0.0003	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Methotrexate—hematologic cancer	7.16e-05	0.0003	CcSEcCtD
Trisalicylate-choline—Oedema—Prednisone—hematologic cancer	7.14e-05	0.000299	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Betamethasone—hematologic cancer	7.13e-05	0.000298	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Dexamethasone—hematologic cancer	7.13e-05	0.000298	CcSEcCtD
Trisalicylate-choline—Nausea—Mitoxantrone—hematologic cancer	7.12e-05	0.000298	CcSEcCtD
Trisalicylate-choline—Nausea—Irinotecan—hematologic cancer	7.12e-05	0.000298	CcSEcCtD
Trisalicylate-choline—Pruritus—Etoposide—hematologic cancer	7.05e-05	0.000295	CcSEcCtD
Trisalicylate-choline—Shock—Prednisone—hematologic cancer	7.03e-05	0.000294	CcSEcCtD
Trisalicylate-choline—Pain—Betamethasone—hematologic cancer	7.01e-05	0.000293	CcSEcCtD
Trisalicylate-choline—Pain—Dexamethasone—hematologic cancer	7.01e-05	0.000293	CcSEcCtD
Trisalicylate-choline—Nausea—Gemcitabine—hematologic cancer	6.93e-05	0.00029	CcSEcCtD
Trisalicylate-choline—Vomiting—Cisplatin—hematologic cancer	6.92e-05	0.000289	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Prednisone—hematologic cancer	6.9e-05	0.000289	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Doxorubicin—hematologic cancer	6.88e-05	0.000288	CcSEcCtD
Trisalicylate-choline—Rash—Cisplatin—hematologic cancer	6.86e-05	0.000287	CcSEcCtD
Trisalicylate-choline—Dermatitis—Cisplatin—hematologic cancer	6.85e-05	0.000287	CcSEcCtD
Trisalicylate-choline—Erythema—Epirubicin—hematologic cancer	6.84e-05	0.000286	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Etoposide—hematologic cancer	6.82e-05	0.000285	CcSEcCtD
Trisalicylate-choline—Anorexia—Prednisone—hematologic cancer	6.81e-05	0.000285	CcSEcCtD
Trisalicylate-choline—Tinnitus—Doxorubicin—hematologic cancer	6.78e-05	0.000284	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Dexamethasone—hematologic cancer	6.76e-05	0.000283	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Betamethasone—hematologic cancer	6.76e-05	0.000283	CcSEcCtD
Trisalicylate-choline—Flushing—Doxorubicin—hematologic cancer	6.75e-05	0.000282	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Epirubicin—hematologic cancer	6.7e-05	0.00028	CcSEcCtD
Trisalicylate-choline—Dizziness—Etoposide—hematologic cancer	6.59e-05	0.000276	CcSEcCtD
Trisalicylate-choline—Urticaria—Dexamethasone—hematologic cancer	6.52e-05	0.000273	CcSEcCtD
Trisalicylate-choline—Urticaria—Betamethasone—hematologic cancer	6.52e-05	0.000273	CcSEcCtD
Trisalicylate-choline—Dizziness—Prednisolone—hematologic cancer	6.5e-05	0.000272	CcSEcCtD
Trisalicylate-choline—Nausea—Cisplatin—hematologic cancer	6.46e-05	0.00027	CcSEcCtD
Trisalicylate-choline—Pruritus—Triamcinolone—hematologic cancer	6.39e-05	0.000267	CcSEcCtD
Trisalicylate-choline—Vomiting—Etoposide—hematologic cancer	6.34e-05	0.000265	CcSEcCtD
Trisalicylate-choline—Erythema—Doxorubicin—hematologic cancer	6.33e-05	0.000265	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Prednisone—hematologic cancer	6.29e-05	0.000263	CcSEcCtD
Trisalicylate-choline—Rash—Etoposide—hematologic cancer	6.28e-05	0.000263	CcSEcCtD
Trisalicylate-choline—Dermatitis—Etoposide—hematologic cancer	6.28e-05	0.000263	CcSEcCtD
Trisalicylate-choline—Headache—Etoposide—hematologic cancer	6.24e-05	0.000261	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Prednisone—hematologic cancer	6.21e-05	0.00026	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Doxorubicin—hematologic cancer	6.2e-05	0.000259	CcSEcCtD
Trisalicylate-choline—Rash—Prednisolone—hematologic cancer	6.2e-05	0.000259	CcSEcCtD
Trisalicylate-choline—Dermatitis—Prednisolone—hematologic cancer	6.19e-05	0.000259	CcSEcCtD
Trisalicylate-choline—Headache—Prednisolone—hematologic cancer	6.16e-05	0.000258	CcSEcCtD
Trisalicylate-choline—Constipation—Prednisone—hematologic cancer	6.11e-05	0.000255	CcSEcCtD
Trisalicylate-choline—Confusional state—Methotrexate—hematologic cancer	6.02e-05	0.000252	CcSEcCtD
Trisalicylate-choline—Dizziness—Triamcinolone—hematologic cancer	5.98e-05	0.00025	CcSEcCtD
Trisalicylate-choline—Nausea—Etoposide—hematologic cancer	5.92e-05	0.000248	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Prednisone—hematologic cancer	5.89e-05	0.000246	CcSEcCtD
Trisalicylate-choline—Nausea—Prednisolone—hematologic cancer	5.84e-05	0.000244	CcSEcCtD
Trisalicylate-choline—Pruritus—Dexamethasone—hematologic cancer	5.8e-05	0.000243	CcSEcCtD
Trisalicylate-choline—Pruritus—Betamethasone—hematologic cancer	5.8e-05	0.000243	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Methotrexate—hematologic cancer	5.77e-05	0.000241	CcSEcCtD
Trisalicylate-choline—Vomiting—Triamcinolone—hematologic cancer	5.75e-05	0.00024	CcSEcCtD
Trisalicylate-choline—Rash—Triamcinolone—hematologic cancer	5.7e-05	0.000238	CcSEcCtD
Trisalicylate-choline—Dermatitis—Triamcinolone—hematologic cancer	5.69e-05	0.000238	CcSEcCtD
Trisalicylate-choline—Anorexia—Methotrexate—hematologic cancer	5.69e-05	0.000238	CcSEcCtD
Trisalicylate-choline—Urticaria—Prednisone—hematologic cancer	5.67e-05	0.000237	CcSEcCtD
Trisalicylate-choline—Headache—Triamcinolone—hematologic cancer	5.66e-05	0.000237	CcSEcCtD
Trisalicylate-choline—Confusional state—Epirubicin—hematologic cancer	5.63e-05	0.000236	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Betamethasone—hematologic cancer	5.61e-05	0.000235	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Dexamethasone—hematologic cancer	5.61e-05	0.000235	CcSEcCtD
Trisalicylate-choline—Oedema—Epirubicin—hematologic cancer	5.59e-05	0.000234	CcSEcCtD
Trisalicylate-choline—Hypotension—Methotrexate—hematologic cancer	5.58e-05	0.000233	CcSEcCtD
Trisalicylate-choline—Shock—Epirubicin—hematologic cancer	5.5e-05	0.00023	CcSEcCtD
Trisalicylate-choline—Dizziness—Dexamethasone—hematologic cancer	5.42e-05	0.000227	CcSEcCtD
Trisalicylate-choline—Dizziness—Betamethasone—hematologic cancer	5.42e-05	0.000227	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Epirubicin—hematologic cancer	5.4e-05	0.000226	CcSEcCtD
Trisalicylate-choline—Nausea—Triamcinolone—hematologic cancer	5.37e-05	0.000225	CcSEcCtD
Trisalicylate-choline—Anorexia—Epirubicin—hematologic cancer	5.32e-05	0.000223	CcSEcCtD
Trisalicylate-choline—Somnolence—Methotrexate—hematologic cancer	5.31e-05	0.000222	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Methotrexate—hematologic cancer	5.25e-05	0.00022	CcSEcCtD
Trisalicylate-choline—Hypotension—Epirubicin—hematologic cancer	5.22e-05	0.000218	CcSEcCtD
Trisalicylate-choline—Vomiting—Betamethasone—hematologic cancer	5.21e-05	0.000218	CcSEcCtD
Trisalicylate-choline—Vomiting—Dexamethasone—hematologic cancer	5.21e-05	0.000218	CcSEcCtD
Trisalicylate-choline—Confusional state—Doxorubicin—hematologic cancer	5.21e-05	0.000218	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Methotrexate—hematologic cancer	5.19e-05	0.000217	CcSEcCtD
Trisalicylate-choline—Rash—Dexamethasone—hematologic cancer	5.17e-05	0.000216	CcSEcCtD
Trisalicylate-choline—Rash—Betamethasone—hematologic cancer	5.17e-05	0.000216	CcSEcCtD
Trisalicylate-choline—Oedema—Doxorubicin—hematologic cancer	5.17e-05	0.000216	CcSEcCtD
Trisalicylate-choline—Dermatitis—Dexamethasone—hematologic cancer	5.17e-05	0.000216	CcSEcCtD
Trisalicylate-choline—Dermatitis—Betamethasone—hematologic cancer	5.17e-05	0.000216	CcSEcCtD
Trisalicylate-choline—Headache—Dexamethasone—hematologic cancer	5.14e-05	0.000215	CcSEcCtD
Trisalicylate-choline—Headache—Betamethasone—hematologic cancer	5.14e-05	0.000215	CcSEcCtD
Trisalicylate-choline—Pain—Methotrexate—hematologic cancer	5.1e-05	0.000214	CcSEcCtD
Trisalicylate-choline—Shock—Doxorubicin—hematologic cancer	5.09e-05	0.000213	CcSEcCtD
Trisalicylate-choline—Pruritus—Prednisone—hematologic cancer	5.05e-05	0.000211	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Doxorubicin—hematologic cancer	5e-05	0.000209	CcSEcCtD
Trisalicylate-choline—Somnolence—Epirubicin—hematologic cancer	4.97e-05	0.000208	CcSEcCtD
Trisalicylate-choline—Anorexia—Doxorubicin—hematologic cancer	4.93e-05	0.000206	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Methotrexate—hematologic cancer	4.92e-05	0.000206	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Epirubicin—hematologic cancer	4.92e-05	0.000206	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Prednisone—hematologic cancer	4.89e-05	0.000204	CcSEcCtD
Trisalicylate-choline—Nausea—Dexamethasone—hematologic cancer	4.87e-05	0.000204	CcSEcCtD
Trisalicylate-choline—Nausea—Betamethasone—hematologic cancer	4.87e-05	0.000204	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Epirubicin—hematologic cancer	4.86e-05	0.000203	CcSEcCtD
Trisalicylate-choline—Hypotension—Doxorubicin—hematologic cancer	4.83e-05	0.000202	CcSEcCtD
Trisalicylate-choline—Constipation—Epirubicin—hematologic cancer	4.78e-05	0.0002	CcSEcCtD
Trisalicylate-choline—Pain—Epirubicin—hematologic cancer	4.78e-05	0.0002	CcSEcCtD
Trisalicylate-choline—PTGS2—Disease—PC—hematologic cancer	4.76e-05	0.000674	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PSIP1—hematologic cancer	4.76e-05	0.000674	CbGpPWpGaD
Trisalicylate-choline—Urticaria—Methotrexate—hematologic cancer	4.74e-05	0.000198	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—hematologic cancer	4.74e-05	0.000671	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Prednisone—hematologic cancer	4.72e-05	0.000198	CcSEcCtD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	4.67e-05	0.000661	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—hematologic cancer	4.66e-05	0.00066	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	4.65e-05	0.000659	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Epirubicin—hematologic cancer	4.6e-05	0.000193	CcSEcCtD
Trisalicylate-choline—Somnolence—Doxorubicin—hematologic cancer	4.59e-05	0.000192	CcSEcCtD
Trisalicylate-choline—PTGS2—Disease—HDAC10—hematologic cancer	4.59e-05	0.000651	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC35B2—hematologic cancer	4.59e-05	0.000651	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	4.55e-05	0.000645	CbGpPWpGaD
Trisalicylate-choline—Dyspepsia—Doxorubicin—hematologic cancer	4.55e-05	0.00019	CcSEcCtD
Trisalicylate-choline—Vomiting—Prednisone—hematologic cancer	4.54e-05	0.00019	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	4.53e-05	0.000642	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HDC—hematologic cancer	4.53e-05	0.000641	CbGpPWpGaD
Trisalicylate-choline—Rash—Prednisone—hematologic cancer	4.5e-05	0.000188	CcSEcCtD
Trisalicylate-choline—Dermatitis—Prednisone—hematologic cancer	4.5e-05	0.000188	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Doxorubicin—hematologic cancer	4.49e-05	0.000188	CcSEcCtD
Trisalicylate-choline—Headache—Prednisone—hematologic cancer	4.47e-05	0.000187	CcSEcCtD
Trisalicylate-choline—Urticaria—Epirubicin—hematologic cancer	4.44e-05	0.000186	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism—MTAP—hematologic cancer	4.43e-05	0.000628	CbGpPWpGaD
Trisalicylate-choline—Pain—Doxorubicin—hematologic cancer	4.42e-05	0.000185	CcSEcCtD
Trisalicylate-choline—Constipation—Doxorubicin—hematologic cancer	4.42e-05	0.000185	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	4.33e-05	0.000613	CbGpPWpGaD
Trisalicylate-choline—Feeling abnormal—Doxorubicin—hematologic cancer	4.26e-05	0.000178	CcSEcCtD
Trisalicylate-choline—Nausea—Prednisone—hematologic cancer	4.24e-05	0.000177	CcSEcCtD
Trisalicylate-choline—Pruritus—Methotrexate—hematologic cancer	4.22e-05	0.000177	CcSEcCtD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	4.22e-05	0.000598	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CDA—hematologic cancer	4.14e-05	0.000586	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	4.12e-05	0.000583	CbGpPWpGaD
Trisalicylate-choline—Urticaria—Doxorubicin—hematologic cancer	4.11e-05	0.000172	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Methotrexate—hematologic cancer	4.08e-05	0.000171	CcSEcCtD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—HRAS—hematologic cancer	4.08e-05	0.000578	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MAPK3—hematologic cancer	4.07e-05	0.000576	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PC—hematologic cancer	3.98e-05	0.000564	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MYC—hematologic cancer	3.96e-05	0.00056	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Epirubicin—hematologic cancer	3.95e-05	0.000165	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism—FHL2—hematologic cancer	3.95e-05	0.00056	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Methotrexate—hematologic cancer	3.95e-05	0.000165	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TGFB1—hematologic cancer	3.95e-05	0.000559	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	3.91e-05	0.000554	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AGRN—hematologic cancer	3.87e-05	0.000549	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	3.85e-05	0.000546	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GBA—hematologic cancer	3.85e-05	0.000545	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC35B2—hematologic cancer	3.85e-05	0.000545	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Epirubicin—hematologic cancer	3.82e-05	0.00016	CcSEcCtD
Trisalicylate-choline—Vomiting—Methotrexate—hematologic cancer	3.8e-05	0.000159	CcSEcCtD
Trisalicylate-choline—Rash—Methotrexate—hematologic cancer	3.76e-05	0.000157	CcSEcCtD
Trisalicylate-choline—Dermatitis—Methotrexate—hematologic cancer	3.76e-05	0.000157	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—hematologic cancer	3.76e-05	0.000533	CbGpPWpGaD
Trisalicylate-choline—Headache—Methotrexate—hematologic cancer	3.74e-05	0.000156	CcSEcCtD
Trisalicylate-choline—Dizziness—Epirubicin—hematologic cancer	3.69e-05	0.000155	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—hematologic cancer	3.68e-05	0.000522	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMMR—hematologic cancer	3.67e-05	0.00052	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—IDH2—hematologic cancer	3.67e-05	0.00052	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SNCA—hematologic cancer	3.67e-05	0.00052	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AGRN—hematologic cancer	3.67e-05	0.00052	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPLP1—hematologic cancer	3.67e-05	0.00052	CbGpPWpGaD
Trisalicylate-choline—Pruritus—Doxorubicin—hematologic cancer	3.66e-05	0.000153	CcSEcCtD
Trisalicylate-choline—Vomiting—Epirubicin—hematologic cancer	3.55e-05	0.000149	CcSEcCtD
Trisalicylate-choline—Nausea—Methotrexate—hematologic cancer	3.55e-05	0.000148	CcSEcCtD
Trisalicylate-choline—PTGS2—Disease—LEF1—hematologic cancer	3.54e-05	0.000502	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Doxorubicin—hematologic cancer	3.54e-05	0.000148	CcSEcCtD
Trisalicylate-choline—Rash—Epirubicin—hematologic cancer	3.52e-05	0.000147	CcSEcCtD
Trisalicylate-choline—PTGS2—Metabolism—MTAP—hematologic cancer	3.52e-05	0.000499	CbGpPWpGaD
Trisalicylate-choline—Dermatitis—Epirubicin—hematologic cancer	3.52e-05	0.000147	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	3.52e-05	0.000498	CbGpPWpGaD
Trisalicylate-choline—Headache—Epirubicin—hematologic cancer	3.5e-05	0.000146	CcSEcCtD
Trisalicylate-choline—PTGS2—Disease—HMMR—hematologic cancer	3.48e-05	0.000493	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.46e-05	0.000491	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ARNTL—hematologic cancer	3.45e-05	0.000489	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	3.45e-05	0.000488	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Doxorubicin—hematologic cancer	3.42e-05	0.000143	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism—CA9—hematologic cancer	3.36e-05	0.000476	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACP5—hematologic cancer	3.36e-05	0.000476	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	3.35e-05	0.000475	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	3.35e-05	0.000474	CbGpPWpGaD
Trisalicylate-choline—Nausea—Epirubicin—hematologic cancer	3.32e-05	0.000139	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism—NCOR2—hematologic cancer	3.32e-05	0.00047	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Doxorubicin—hematologic cancer	3.29e-05	0.000137	CcSEcCtD
Trisalicylate-choline—PTGS2—Disease—ELL—hematologic cancer	3.27e-05	0.000464	CbGpPWpGaD
Trisalicylate-choline—Rash—Doxorubicin—hematologic cancer	3.26e-05	0.000136	CcSEcCtD
Trisalicylate-choline—Dermatitis—Doxorubicin—hematologic cancer	3.26e-05	0.000136	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TP53—hematologic cancer	3.25e-05	0.00046	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	3.24e-05	0.00046	CbGpPWpGaD
Trisalicylate-choline—Headache—Doxorubicin—hematologic cancer	3.24e-05	0.000135	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	3.24e-05	0.000459	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ACP5—hematologic cancer	3.18e-05	0.000451	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	3.17e-05	0.000449	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—IDH1—hematologic cancer	3.16e-05	0.000448	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NCOR2—hematologic cancer	3.14e-05	0.000445	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FHL2—hematologic cancer	3.14e-05	0.000444	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TXN—hematologic cancer	3.12e-05	0.000443	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTO1—hematologic cancer	3.12e-05	0.000443	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCC3—hematologic cancer	3.12e-05	0.000443	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	3.09e-05	0.000437	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AGRN—hematologic cancer	3.08e-05	0.000436	CbGpPWpGaD
Trisalicylate-choline—Nausea—Doxorubicin—hematologic cancer	3.07e-05	0.000128	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism—SPHK1—hematologic cancer	3.06e-05	0.000433	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	3e-05	0.000425	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IDH1—hematologic cancer	2.99e-05	0.000424	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	2.97e-05	0.000421	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GSTO1—hematologic cancer	2.96e-05	0.000419	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—UGT1A1—hematologic cancer	2.94e-05	0.000416	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.92e-05	0.000414	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—IDH2—hematologic cancer	2.92e-05	0.000413	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMMR—hematologic cancer	2.92e-05	0.000413	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AGO2—hematologic cancer	2.9e-05	0.000411	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HDAC9—hematologic cancer	2.87e-05	0.000406	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CRABP1—hematologic cancer	2.86e-05	0.000405	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC22A1—hematologic cancer	2.86e-05	0.000405	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—H3F3B—hematologic cancer	2.84e-05	0.000402	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALOX5—hematologic cancer	2.78e-05	0.000394	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.77e-05	0.000392	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.75e-05	0.00039	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ARNTL—hematologic cancer	2.74e-05	0.000388	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NPM1—hematologic cancer	2.73e-05	0.000387	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NUP98—hematologic cancer	2.7e-05	0.000382	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.69e-05	0.000381	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.68e-05	0.00038	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA9—hematologic cancer	2.67e-05	0.000378	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACP5—hematologic cancer	2.67e-05	0.000378	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NCOR2—hematologic cancer	2.63e-05	0.000373	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ADCY7—hematologic cancer	2.62e-05	0.000371	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NCOA3—hematologic cancer	2.62e-05	0.000371	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF19—hematologic cancer	2.62e-05	0.000371	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NUP214—hematologic cancer	2.6e-05	0.000368	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPS14—hematologic cancer	2.6e-05	0.000368	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—DKK1—hematologic cancer	2.58e-05	0.000365	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.57e-05	0.000364	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT5B—hematologic cancer	2.56e-05	0.000362	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NUP98—hematologic cancer	2.56e-05	0.000362	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTR—hematologic cancer	2.55e-05	0.000361	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCG2—hematologic cancer	2.55e-05	0.000361	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—IDH1—hematologic cancer	2.51e-05	0.000355	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.51e-05	0.000355	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CST3—hematologic cancer	2.5e-05	0.000354	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ENO2—hematologic cancer	2.5e-05	0.000354	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.49e-05	0.000352	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ADCY7—hematologic cancer	2.48e-05	0.000352	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCC3—hematologic cancer	2.48e-05	0.000351	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTO1—hematologic cancer	2.48e-05	0.000351	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TXN—hematologic cancer	2.48e-05	0.000351	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NUP214—hematologic cancer	2.46e-05	0.000349	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SPHK1—hematologic cancer	2.43e-05	0.000344	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTT1—hematologic cancer	2.42e-05	0.000343	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—XIAP—hematologic cancer	2.41e-05	0.000342	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTR—hematologic cancer	2.41e-05	0.000342	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.38e-05	0.000338	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SDC1—hematologic cancer	2.37e-05	0.000335	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ENO2—hematologic cancer	2.37e-05	0.000335	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SMARCA4—hematologic cancer	2.35e-05	0.000333	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UGT1A1—hematologic cancer	2.33e-05	0.00033	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.28e-05	0.000324	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CRABP1—hematologic cancer	2.27e-05	0.000321	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC22A1—hematologic cancer	2.27e-05	0.000321	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.26e-05	0.00032	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SDC1—hematologic cancer	2.24e-05	0.000318	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.23e-05	0.000316	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALOX5—hematologic cancer	2.21e-05	0.000313	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.21e-05	0.000313	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LCK—hematologic cancer	2.17e-05	0.000308	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NUP98—hematologic cancer	2.14e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.14e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—H3F3A—hematologic cancer	2.13e-05	0.000302	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ADCY7—hematologic cancer	2.08e-05	0.000294	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NCOA3—hematologic cancer	2.08e-05	0.000294	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKCZ—hematologic cancer	2.07e-05	0.000293	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NUP214—hematologic cancer	2.06e-05	0.000292	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.04e-05	0.000289	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CALR—hematologic cancer	2.03e-05	0.000288	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTR—hematologic cancer	2.02e-05	0.000286	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCG2—hematologic cancer	2.02e-05	0.000286	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NQO1—hematologic cancer	2.01e-05	0.000285	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CD44—hematologic cancer	2.01e-05	0.000285	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PARP1—hematologic cancer	2e-05	0.000283	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ENO2—hematologic cancer	1.98e-05	0.000281	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.97e-05	0.000279	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FBXW7—hematologic cancer	1.97e-05	0.000279	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CXCR4—hematologic cancer	1.93e-05	0.000273	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HDAC2—hematologic cancer	1.93e-05	0.000273	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTT1—hematologic cancer	1.92e-05	0.000272	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD44—hematologic cancer	1.91e-05	0.00027	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYCS—hematologic cancer	1.9e-05	0.00027	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.89e-05	0.000268	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSP90AA1—hematologic cancer	1.89e-05	0.000268	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CBL—hematologic cancer	1.88e-05	0.000266	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SDC1—hematologic cancer	1.88e-05	0.000266	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.87e-05	0.000264	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.79e-05	0.000254	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HSP90AA1—hematologic cancer	1.79e-05	0.000254	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.77e-05	0.000251	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT1—hematologic cancer	1.73e-05	0.000245	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.7e-05	0.000241	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.69e-05	0.00024	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTP1—hematologic cancer	1.68e-05	0.000238	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.62e-05	0.00023	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GRB2—hematologic cancer	1.62e-05	0.000229	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PDGFA—hematologic cancer	1.61e-05	0.000229	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NQO1—hematologic cancer	1.6e-05	0.000226	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CD44—hematologic cancer	1.6e-05	0.000226	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KITLG—hematologic cancer	1.59e-05	0.000225	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCB1—hematologic cancer	1.59e-05	0.000225	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.56e-05	0.000222	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT5A—hematologic cancer	1.56e-05	0.00022	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTM1—hematologic cancer	1.54e-05	0.000219	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NCOR1—hematologic cancer	1.54e-05	0.000219	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN2B—hematologic cancer	1.54e-05	0.000218	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYCS—hematologic cancer	1.51e-05	0.000214	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.5e-05	0.000213	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD86—hematologic cancer	1.49e-05	0.000211	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HES1—hematologic cancer	1.47e-05	0.000208	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NCOR1—hematologic cancer	1.46e-05	0.000207	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF1—hematologic cancer	1.45e-05	0.000205	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FOXO1—hematologic cancer	1.42e-05	0.000202	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PDGFRB—hematologic cancer	1.42e-05	0.000202	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PDGFRA—hematologic cancer	1.4e-05	0.000198	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—JAK1—hematologic cancer	1.4e-05	0.000198	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKCG—hematologic cancer	1.4e-05	0.000198	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTHFR—hematologic cancer	1.36e-05	0.000193	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.35e-05	0.000192	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTP1—hematologic cancer	1.33e-05	0.000189	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTHFR—hematologic cancer	1.29e-05	0.000183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.29e-05	0.000183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HLA-A—hematologic cancer	1.29e-05	0.000183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TERT—hematologic cancer	1.29e-05	0.000183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCB1—hematologic cancer	1.26e-05	0.000179	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PDGFB—hematologic cancer	1.26e-05	0.000178	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TSC2—hematologic cancer	1.23e-05	0.000174	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NCOR1—hematologic cancer	1.22e-05	0.000174	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTM1—hematologic cancer	1.22e-05	0.000174	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.2e-05	0.00017	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGFR3—hematologic cancer	1.18e-05	0.000168	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CG—hematologic cancer	1.15e-05	0.000162	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—BAD—hematologic cancer	1.12e-05	0.000159	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOTCH1—hematologic cancer	1.11e-05	0.000157	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD80—hematologic cancer	1.09e-05	0.000154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KIT—hematologic cancer	1.09e-05	0.000154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTHFR—hematologic cancer	1.08e-05	0.000153	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PTPN11—hematologic cancer	1.07e-05	0.000151	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CREBBP—hematologic cancer	1.06e-05	0.00015	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CREB1—hematologic cancer	1.03e-05	0.000146	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—BRAF—hematologic cancer	1.02e-05	0.000145	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6R—hematologic cancer	1.01e-05	0.000143	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CD—hematologic cancer	1.01e-05	0.000143	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CREBBP—hematologic cancer	1.01e-05	0.000143	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—hematologic cancer	9.94e-06	0.000141	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAP2K1—hematologic cancer	9.61e-06	0.000136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CD—hematologic cancer	9.54e-06	0.000135	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.54e-06	0.000135	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3R1—hematologic cancer	9.51e-06	0.000135	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF2—hematologic cancer	9.14e-06	0.000129	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CG—hematologic cancer	9.09e-06	0.000129	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3R1—hematologic cancer	9.01e-06	0.000128	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CB—hematologic cancer	8.78e-06	0.000124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—JAK2—hematologic cancer	8.76e-06	0.000124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MDM2—hematologic cancer	8.55e-06	0.000121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CREBBP—hematologic cancer	8.43e-06	0.000119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTOR—hematologic cancer	8.32e-06	0.000118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CB—hematologic cancer	8.32e-06	0.000118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD4—hematologic cancer	8.3e-06	0.000118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CD—hematologic cancer	7.99e-06	0.000113	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—hematologic cancer	7.89e-06	0.000112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1B—hematologic cancer	7.81e-06	0.000111	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTEN—hematologic cancer	7.58e-06	0.000107	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3R1—hematologic cancer	7.55e-06	0.000107	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—EP300—hematologic cancer	7.23e-06	0.000102	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1A—hematologic cancer	7.21e-06	0.000102	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PTEN—hematologic cancer	7.19e-06	0.000102	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CB—hematologic cancer	6.97e-06	9.87e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EP300—hematologic cancer	6.86e-06	9.71e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SRC—hematologic cancer	6.67e-06	9.45e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT3—hematologic cancer	6.43e-06	9.11e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NRAS—hematologic cancer	6.41e-06	9.09e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAPK3—hematologic cancer	6.14e-06	8.7e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PTEN—hematologic cancer	6.02e-06	8.53e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MYC—hematologic cancer	5.97e-06	8.47e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFB1—hematologic cancer	5.96e-06	8.44e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—EP300—hematologic cancer	5.74e-06	8.14e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KRAS—hematologic cancer	5.52e-06	7.82e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CA—hematologic cancer	5.35e-06	7.58e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CA—hematologic cancer	5.07e-06	7.19e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HRAS—hematologic cancer	4.69e-06	6.65e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—hematologic cancer	4.49e-06	6.36e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKT1—hematologic cancer	4.37e-06	6.19e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CA—hematologic cancer	4.25e-06	6.02e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT1—hematologic cancer	4.14e-06	5.87e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKT1—hematologic cancer	3.47e-06	4.92e-05	CbGpPWpGaD
